InVivo Therapeutics Holdings buy BiotechBee
Start price
10.01.23
/
50%
€2.16
Target price
31.12.25
€4.00
Performance (%)
-46.57%
End price
05.05.23
€1.15
Summary
This prediction ended on 05.05.23 with a price of €1.15. Massive losses of -46.57% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| InVivo Therapeutics Holdings | - | - | - | - |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % | 53,20 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % | 91,09 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % | 63,93 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % | 64,84 % |
According to BiotechBee what are the pros and cons of InVivo Therapeutics Holdings for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year